TG Therapeutics Inc (NASDAQ:TGTX)
| 18.85 BATS BZX Real-Time Price As of 12:55pm ET |  +0.17 / +0.91%Today’s Change | 4.95 Today|||52-Week Range 24.76 | +69.82% Year-to-Date |
Latest TGTX News | Press Releases
| Biotech Bonanza - Second Half Outlook Jul 28 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 18.68 |
| Today’s open | 20.78 |
| Day’s range | 17.85 - 19.27 |
| Volume | 52,376 |
| Average volume (3 months) | 2,050,772 |
| Market cap | $2.5B |
Data as of 12:55pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | +14.90% |
| Earnings growth (this year) | +19.81% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 6,453.25 |
| Price/Book | 59.49 |
Competitors
Data as of 12:56pm ET, 08/11/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $152.0K |
| Annual profit (last year) | -$172.9M |
| Net profit margin | -113,730.92% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
